Judiora Buccal Paste contains Triamcinolone Acetonide 0.1% w/w, a potent synthetic corticosteroid with anti-inflammatory, immunosuppressive, and antiproliferative properties. It is specifically formulated for topical application to the buccal mucosa to manage inflammatory and ulcerative conditions of the oral cavity, such as aphthous stomatitis, oral lichen planus, and other corticosteroid-responsive mucosal lesions. The paste base ensures prolonged contact with the mucosal surface, enhancing local drug absorption and therapeutic efficacy while minimizing systemic exposure. Judiora Buccal Paste works by inhibiting the release of inflammatory mediators and suppressing the immune response, thereby reducing pain, swelling, and erythema associated with oral mucosal inflammation. It is intended for short-term use under medical supervision, with careful adherence to prescribed dosage to avoid potential adverse effects such as mucosal thinning or secondary infections. Patients should apply a thin layer of the paste directly to the affected area, typically two to three times daily, avoiding ingestion or contact with other oral surfaces. Judiora Buccal Paste is contraindicated in patients with known hypersensitivity to corticosteroids or any excipients in the formulation. Use during pregnancy and lactation should be under strict medical guidance.